Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration
April 09, 2024 08:08 ET
|
Tome Biosciences
Tome granted US patent for programmable genomic integration.
Auddia Announces Issuance of Core AI Patent
April 08, 2024 08:00 ET
|
Auddia Inc.
U.S. Patent 11,935,520 titled ‘Identifying Shifts in Audio Content Via Machine Learning’ supports the core AM/FM AI model used within faidr Company advances its patent application for...
Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method
April 08, 2024 07:00 ET
|
Pluri Inc.
Pluri’s patent enables mass-scale production of immune cell therapiesNew patented technology is applicable for the expansion of a variety of immune cellsTechnology sets stage for potential immune cell...
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
April 04, 2024 13:00 ET
|
Nexalin Technology, Inc.
HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO)...
SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India, for its Advanced, Smart Home and AI Platform Technologies
April 04, 2024 09:22 ET
|
SKYX Platforms Corp.
SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India
Recce Pharmaceuticals Granted New Patent in Israel for RECCE® Anti-Infectives
April 04, 2024 08:00 ET
|
Recce Pharmaceuticals
SYDNEY, Australia, April 04, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, today announced that the State...
Medigene AG Secures European Patent for its iM-TCR Technology
April 04, 2024 05:00 ET
|
Medigene AG
Planegg/Martinsried, April 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid...
BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
April 03, 2024 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer of innovative treatment programs for substance use and related...
Becklar Patents AI-Powered Engage Platform to Accelerate Decision Making in the Moments that Matter
April 03, 2024 08:00 ET
|
Becklar
Ogden, Utah, April 03, 2024 (GLOBE NEWSWIRE) -- Becklar, the parent company of AvantGuard, Eyeforce, Armstrongs, and Freeus, is pleased to announce its successful patent of their AI-powered event...
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
April 03, 2024 08:00 ET
|
Amarin Corporation plc
DUBLIN, Ireland and BRIDGEWATER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company received a Decision to Grant from the European Patent...